EUVIMEDEUVIMED entdecken
Crossref

Reliability of Hepatus® for Evaluating Liver Fibrosis in Chronic Hepatitis B

Jessica Cynthia Febryani, Muhammad Begawan Bestari, Haryono -, Dolvy Girawan, Nenny Agustanti, Yudi Wahyudi, Siti Aminah Abdurachman

The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy · 06.09.2022 · 23 (2) · 212-216

DOI: 10.24871/2322022212-216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, online erschienen am 06.09.2022. Verfasst von Jessica Cynthia Febryani und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundAmong non-invasive strategies available for liver fibrosis assessment, transient elastography is widely used, as it is non-invasive and can be repeated. Hepatus® (Mindray, China) is one novel instrument for measuring liver stiffness that is now available in the market with lower price than its precursor, FibroScan® (Echosens, Paris). MethodIn this cross sectional study, CHB patients in single center were recruited consecutively in October 2021-December 2021. The patients were examined for LSM with two transient elastography instruments in one visit. The first instrument was Hepatus® (Mindray, China) and the second one was FibroScan® (Echosens, Paris). Both measurements were done by the same operator. ResultsA total of 68 CHB patients were enrolled in this study. Median score of LSM by Hepatus® and FibroScan® were 7.6 (5.92-11.88) and 7.35 (5.63-11.80) respectively. Spearman rank analysis for correlation showed a significant correlation between the results of the two instruments ( r= 0.8, p 0.05). The number of patients with significant fibrosis (≥8 kPa) identified by Hepatus® and FibroScan® were 28 (41%) and 29 (43%) respectively. McNemar test yielded no significant difference of the results (p= 1.000), and Cohen’s kappa measure of agreement showed moderate agreement (κ = 0.789 and p 0.005). ConclusionHepatus® identified similar number of significant fibrosis patients with FibroScan®, with the results of liver stiffness measurement between the two instruments correlated significantly. Hepatus® has a potential as an alternative tool for measuring liver stiffness with a more economic price. KeywordsHepatus®, FibroScan®, transient elastography, liver fibrosis, CHB

Zitieren

APA

Febryani, J. C., Bestari, M. B., -, H., Girawan, D., Agustanti, N., Wahyudi, Y., & Abdurachman, S. A. (2022). Reliability of Hepatus® for Evaluating Liver Fibrosis in Chronic Hepatitis B. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 23(2), 212-216. https://doi.org/10.24871/2322022212-216

Vancouver

Febryani JC, Bestari MB, - H, Girawan D, Agustanti N, Wahyudi Y, et al. Reliability of Hepatus® for Evaluating Liver Fibrosis in Chronic Hepatitis B. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 2022;23(2):212-216. doi:10.24871/2322022212-216

BibTeX
@article{Febryani2022,
  author = {Febryani, Jessica Cynthia and Bestari, Muhammad Begawan and -, Haryono and Girawan, Dolvy and Agustanti, Nenny and Wahyudi, Yudi and Abdurachman, Siti Aminah},
  title = {Reliability of Hepatus® for Evaluating Liver Fibrosis in Chronic Hepatitis B},
  journal = {The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy},
  year = {2022},
  volume = {23},
  number = {2},
  pages = {212--216},
  doi = {10.24871/2322022212-216}
}
Kostenlos starten →